Rheumatology Headlines
Dr. Patel and Dr. Shah Talk About Pain Management and the Opioid Crisis During...
During an interview with DocWire News, Shalini Shah, MD, vice-chair and associate professor, Department of Anesthesiology & Perioperative Care, and enterprise director of pain services at UC Irvine Health, and Nilesh Patel, MD, MBA,...
Latest Abstracts
New from Around the Web
Today's Top 5
5. First Lupus Nephritis Drug Approved
FDA approves Lupkynis, first-ever oral therapy for lupus nephritis. Let’s hope this paves the way for many more #lupus drugs! @CreakyJoints @Lupus_Chat @Looms4Lupus @AARDATweets @IFAiArthritis @colorofcci https://t.co/jVAKFQ7rem
— Lupus Association (@LADAOrg) January 25, 2021
4. Avascular Necrosis of the Knee
Avascular necrosis of the #knee on #MRI
— Dr Ai Lyn Tan (@DrAiLynTan) January 26, 2021
👉🏽https://t.co/7HguR2BVHj
via @RadiologySigns
Characteristic features
➡️Double line sign
▶️https://t.co/dH2YIpYDJA
➡️Rim sign
▶️https://t.co/VTDBoDnqq5 pic.twitter.com/9jo7fEV9SL
3. Nonadherence in Methotrexate on the Decline
Despite the limitations of the study, non-adherence rates of #methotrexate were significantly reduced in patients observed throughout the 3 years, indicating that the methods developed and deployed were successful. #RheumatoidArthritishttps://t.co/hzBItZfDvv
— Rheumatology Network (@RheumatologyNet) January 26, 2021
2. Predicting Flares
Is it possible to predict pain flares through clustering #pain trajectories using daily reported pain data? Can we measure pain more effectively than has been possible via an innovative digital mannikin? @clairelittlephd & Mustafa discuss their exciting plans @CfE_UoM Sci Meeting pic.twitter.com/rjvY7M651e
— Meghna Jani (@MeghnaJani) January 27, 2021
1. TNFi Use in PsA
The use of tumor necrosis factor #TNF inhibitors in patients with #psoriaticarthritis does not increase the risk of solid cancer, according to a study published in #rheumatologyhttps://t.co/UqfBakc9qf
— Rheumatology Network (@RheumatologyNet) January 27, 2021